An Open-Label, Single-Dose Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of Radiolabeled Androxal in Healthy Male Subjects After Oral Administration
Phase of Trial: Phase I
Latest Information Update: 18 Mar 2015
At a glance
- Drugs Enclomifene (Primary)
- Indications Hypogonadism
- Focus Pharmacokinetics
- Sponsors Repros Therapeutics
- 11 Mar 2015 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov record.
- 28 Oct 2014 Celerion is Clinical research organization. It is not a pharmaceutical company.
- 28 Oct 2014 New trial record